Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00058214
What this trial is testing

Perifosine in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)UnknownNCT06015321
What this trial is testing

An Open Label Phase II Study of First-Line Maintenance Enzalutamide Following Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Castration-Naive Prostatic Adenocarcinoma

Who this might be right for
Prostatic Adenocarcinoma
Samsung Medical Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT06798558
What this trial is testing

Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Who this might be right for
Prostate Adenocarcinoma
Hackensack Meridian Health 54
Early research (Phase 1)Study completedNCT01028885
What this trial is testing

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate Cancer+2 more
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Ended earlyNCT01145508
What this trial is testing

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 10
Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)WithdrawnNCT00769990
What this trial is testing

Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases

Who this might be right for
Breast CancerKidney CancerLung Cancer+4 more
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT01832259
What this trial is testing

VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection

Who this might be right for
Adenocarcinoma of the Prostate
University of Utah 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT01994239
What this trial is testing

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Who this might be right for
Adenocarcinoma of Prostate
UNICANCER 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03371719
What this trial is testing

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

Who this might be right for
Recurrent Prostate CarcinomaStage III Prostate Adenocarcinoma AJCC v7Stage IV Prostate Adenocarcinoma AJCC v7
NRG Oncology 298
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT05168618
What this trial is testing

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
University of Utah 33
Not applicableStudy completedNCT02254746
What this trial is testing

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Centre Hospitalier Universitaire Vaudois 27
Testing effectiveness (Phase 2)Ended earlyNCT04019327
What this trial is testing

The Drugs Talazoparib and Temozolomide in Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Study completedNCT00188513
What this trial is testing

Intensity Modulated Radiation Therapy - Prostate Cancer

Who this might be right for
Prostatic Neoplasms
University Health Network, Toronto 267
Testing effectiveness (Phase 2)WithdrawnNCT03147196
What this trial is testing

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate Adenocarcinoma
Mayo Clinic
Early research (Phase 1)Study completedNCT00804245
What this trial is testing

C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 18
Testing effectiveness (Phase 2)Study completedNCT00081172
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Next Page